Novel strategies for the detection of systolic and diastolic heart failure

Current Cardiology Reviews

Volumn 5, Issue 2, 2009, Pages 112-118

  Lodewijks Bolt, Cara ^a   Baur, Leo ^a,b   Stoffers, Jelle ^b   Lenderink, Timo ^a   Winkens, Ron ^b  

^a Sittard Geleen Heerlen   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Brain natriuretic peptide; Diastolic dysfunction; Echocardiography; Heart failure; Systolic dysfunction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

DIASTOLE; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART VENTRICLE PRESSURE; HEART VOLUME; HUMAN; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; THORAX RADIOGRAPHY; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 68449091261     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340309788166651     Document Type: Review

References (54)

1. Rodeheffer RJ, Jacobsen SJ, Gersh BJ, et al. The incidence and prevalence of congestive heart failure in Rochester, Minnesota. Mayo Clin Proc 1993; 68: 1143-1150.
2. Shah SJ, Georghiade M. Heart Failure with preserved ejection fraction. Treat now by treating comorbidities. JAMA 2008; 300: 431-433.
3. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002; 106: 3068-3072.
4. Shah SJ, Georghiade M. Heart Failure with preserved ejection fraction. Treat now by treating comorbidities. JAMA 2008; 300: 431-433
5. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
6. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998; 352 (suppl): 3-7.
7. Wilson Tang WH, Hobbs RE. Novel strategies for the management of acute decompensated heart failure. Curr Cardiol Rev 2005; 1: 1-5.
8. Cline CMJ, Israelsson BYA,Willenheimer R, Broms K, Erhardt LR. Cost effective management programme for heart failure reduces hospitalization. Heart 1998; 80: 442-446.
9. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-321.
10. Zile MR, Baicu CF, Bonnema DD. Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis 2005; 47: 307-313.
11. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation 2003; 107: 659-663.
12. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Circulation 1998; 98: 2282; adapted from McKee PA, Castelli WP, McNamara PM, Kannel WB. N Engl J Med 1971; 85: 1441.
13. Cowie MR, Struthers AD, Wood DA, Coats AJS, Thompson SG, Poole-Wilson PA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1347-151.
14. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154.
15. Struthers AD. Prospects for using a blood sample in the diagnosis of heart failure. Q J Med 1993; 86: 17-20.
16. Richards AM, Crozier IG, Yandle TG, Espiner EA, Ikram H, Nicholls MG. Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. Br Heart J 1993; 69: 414-17.
17. NT-pro BNP Testing for diagnosis and short term prognosis in acute destabilized heart failure: An international pooled analysis of 1256 patients. Eur Heart J 2006; 27: 330-337.
18. Lee SC, Stevens TL, Dandberg SM, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association Class during the outpatient treatment of heart failure. J Card Fail 2002; 8: 149-154.
19. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-22.
20. Vasan RS, Benjamin EJ, Larson MG, et al. Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study. JAMA 2002; 288: 1252-59.
21. McCullough PA, Nowak RM, McCord, et al. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) National Study. Circulation 2002; 106: 416-422.
22. Grewal J, McKelvie R, Lonn E, et al. BNP and NT- proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008; 10: 252-259.
23. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of Bnatriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 105: 595-601.
24. Nagaya N, Nishikimi T, Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of riht ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208.
25. Akiba T, Tachibana K, Togashi K, Hiroc M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995; 44: S61-S64.
26. Wang TJ, Larson MG, Levy D, et al. Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am J Cardiol 2002; 90: 254-258.
27. Lodewijks-vd Bolt CLB, Baur LHB, Lenderink T, et al. The dutch experience of open access echocardiography. Neth Heart J 2007; 15: 432-437.
28. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995; 26: 1565-1574.
29. Goldsmith SR, Dick C. Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations. Am J Med 1993; 95: 645-655.
30. Brutsaert DL, Rademakers FE, Sys SU, et al. Analysis of relaxation in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis 1985; 28: 143-163.
31. Rahko Ps, Shaver JA, Salerni R, Uretsky BF. Noninvasive evaluation of systolic and diastolic function in severe congestive heart failure secondary to coronary artery disease or dilated cardiomyopathy. Am J Cardiol 1986; 57: 1315-1322.
32. Appleton CP, Hattle LK, Popp RL. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol. 1988; 11: 757-768.
33. Klein AL, Burstow DJ, Tajik AJ, et al. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc 1994; 69: 212-224.
34. Appleton CP, Hatle LK. The natural history of left ventricular filling abnormalities: Assessment by two-dimensional and Doppler echocardiography. Echocardiography 1992; 9: 437-457.
35. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: A noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-1533.
36. Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997; 30: 474-480.
37. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997; 30: 1527-33.
38. Bulkley BH. Site and sequelae of myocardial infraction. N Engl J Med 1981; 305: 337-338.
39. Onodera T, Tamura T, Said S, McCune SA, Gerdes AM. Maladaptive remodeling of cardiac myocyte shape begins long before failure in hypertension. Hypertension 1998; 32: 753-757.
40. Cohn JN. Structural basis for heart failure: ventricular remodeling and its pharmacologic inhibition. Circulation 1995; 91: 2504-2506.
41. Mc Donagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-833.
42. McDonagh TA, Robb SD, Murdoch DR et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13.
43. Feigenbaum H, Armstrong WF, Ryan T. Feigenbaum's Echocadiography. Lippincott Williams & Wilkins 6th ed. 2005.
44. Gopal AS, Keller AM, Rigling R, et al. Left ventricular volume and endocardial surface area by three-dimensional echocardiography: comparison with two-dimensional echocardiography and nuclear magnetic resonance imaging in normal subjects. J Am Coll Cardiol 1993; 22:258.
45. Fukuda K, Oki T, Tabata T, Luchi A, Ito S. Regional left ventricular wall motion abnormalities in myocardial infarction and mitral annular descent velocities studied with pulsed tissue Doppler imagingL in vitro and in vivo results. J Am Soc Echocard 1998; 11: 841-848.
46. Bax JJ, Marwick SG, Molhoek GG, et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end stage heart failure before pacemaker implantation. Am J Cardiol 2004; 94: 817-820.
47. Sutherland GR, Di Salvo G, Claus P, D'hooge J. Bijnens B Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial function. J Am Soc Echocardiogr 2004; 17: 788-802.
48. Remes J, Miettinen H, Reunanen A, Pyorala K. Validity of clinical diagnosis of heart failure in primairy helth care. Eur Heart J 1991; 12: 315-321.
49. Francis CM, Caruana L, Kearney P, et al. Open access echocardiography in management of heart failure in the community. BMJ 1995; 310: 634-636.
50. Williams S, Currie P, Silas JH. Open access echocardiography: a prospective audit of referral patterns from primary care. Int J Clin Pract 2003; 57: 136-139.
51. Baur LHB, Lenderink T, Lodewijks C, Veenstra L, Winkens R. Easy access echocardiography for the general practitioner: results from the Parkstad Area in the Netherlands. Int J Cardiac Imaging 2006: 22: 19-25.
52. Chambers J, Sprigings D, De Bono D, on behalf of the working group on open acces echocardiography. Open Access Echocardiography. Br J Cardiol 2001; 8: 365-373.
53. Khunti K. Systematic review of open access echocardiography for primary care. Eur J Haert Fail 2004; 6: 79-83.
54. Sim V, Hampton D, Philips C, et al. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunctioncost effectiveness in relation to open access echocardiography. Fam Prac 2003; 20: 570-574.